Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
Sponsor: Massachusetts General Hospital
A observational or N/A phase clinical study on Chronic Liver Disease and HepatoCellular Carcinoma, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 8 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 3 earlier versions
-
Jun 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Feb 2017 — Jun 2017 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .